Top Markets
Coin of the day
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUP
Rank in Stocks #29434
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Share Price
$3.92
Last synced: 2026-07-31
Market Cap
$21.16M
Change (1 day)
-0.13%
Change (1 year)
-48.76%
Country
US
Trade Neuphoria Therapeutics Inc. (NEUP)

Category

Earnings for Neuphoria Therapeutics Inc. (NEUP)
Earnings in 2026 TTM: 0
According to Neuphoria Therapeutics Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Neuphoria Therapeutics Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -
US
$1.95B -
NL
$-3.09B -
US
$1.61B -
AU
- -
CH